|
Posted: SEPT 4, 2008
CSMG
Technologies Expands Corporate Home Office to Facilitate
Company Growth
Corpus Christi, TX, September 4, 2008 -- CSMG Technologies,
Inc., (OTCBB: CTGI
- News),
a technology management company, announced the company
is today moving its corporate home office, expanding
into larger office space in order to accommodate additional
personnel, its growing core business, and to support
growth of its Live Tissue Connect subsidiary, headquartered
in Santa Barbara, CA. The new address is 500 North Shoreline,
Suite 1005, Corpus Christ, TX 78471.
About CSMG Technologies, Inc.
CSMG Technologies, Inc. (OTCBB: CTGI)
together with its subsidiaries, operates as a technology
management company. The company engages in owning, developing,
patenting, managing, licensing, and marketing technologies.
Subsidiary Live Tissue Connect (LTC) provides live
biological tissue bonding technology that focuses on
bonding living soft biological tissue used in surgical
procedures, without the use of sutures, staples, sealants,
or glues.
In June 2008, CSMG acquired Carbon Capture Technologies
Inc. which owns a worldwide exclusive license to a composition
and method for use of a novel Carbon Dioxide (CO2) adsorbent.
Researchers at the University of Ottawa developed recyclable
CO2 adsorbents based on surface modified nanoporous
silicas. The materials show fast and reversible high
adsorption capacity, allowing it to be reused repeatedly
in a high throughput periodic cyclic adsorption process.
The adsorbents can be used in both wet and dry environments,
potentially eliminating significant engineering challenges.
The potential uses for the technology include capturing
the bulk of C02 emissions from coal-fired power plants
in order that these greenhouse gasses could be sequestered
and thus reduce the carbon footprint of such facilities,
as well as surgical and mine rescue applications.
CSMG was incorporated in 1992 and is headquartered
in Corpus Christi, Texas.
About Live Tissue Connect
LTC received this July, U.S. FDA 510(k) clearance to
market its LTC VAD System for Duct and Vessel sealing
in the United States, and this month was awarded CE
Mark (Conformité Europèéne) certification
for its Bipolar Forceps by BSI Product Services in its
capacity as Notified Body for the Council Directive
93/42/EEC, allowing LTC to market in the European Union.
LTC's surgical tissue bonding / welding device
is a patented platform technology that bonds and reconnects
human soft tissue through fusion, in contrast with conventional
wound closing devices such as sutures, staples, sealant,
or glues. LTC currently holds a total of approximately
31 patents and pending patents in the U.S., Australia,
Canada, European Union, Ukraine and other countries.
For further information on CSMG Technologies and its various subsidiaries, please visit our website at www.csmgtechinternational.com.
Sign up to receive CSMG Technologies automated email press releases and other notifications: Please go to: www.csmgtechinternational.com/contact_information.html and fill-in information.
This press release may contain forward-looking information
within the meaning of Section 21E of the Securities
Exchange Act of 1934 as amended (the Exchange Act),
including all statements that are not statements of
historical fact regarding the intent, belief or current
expectations of the company, its directors or its officers
with respect to, among other things: (i) the company's
financing plans; (ii) trends affecting the company's
financial condition or results of operations; (iii)
the company's growth strategy and operating strategy;
and (iv) the declaration and payment of dividends. The
words "may," "would," "will,"
"expect," "estimate," "anticipate,"
"believe," "intend" and similar
expressions and variations thereof are intended to identify
forward-looking statements. Investors are cautioned
that any such forward-looking statements are not guarantees
of future performance and involve risks and uncertainties,
many of which are beyond the company's ability to control,
and that actual results may differ materially from those
projected in the forward-looking statements as a result
of various factors.
CONTACT:
CSMG Technologies, Inc.
Donald S. Robbins, 361-887-7546
President and CEO
or
K. Bruce Jones, 770-955-0409
|
